[1]
Al-Azawi , A. et al. 2023. The Effect of Adding Pertuzumab to Adjuvant Trastuzumab in Early HER2-Positive Breast Cancer. Journal of Contemporary Medical Sciences. 9, 3 (Jun. 2023), 197–200. DOI:https://doi.org/10.22317/jcms.v9i3.1351.